Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Israel stocks rise, led by Teva, ICL - MarketWatch
Teva Poised to Get a Big Boost in Generics - WSJ
Teva Pharmaceutical to pay $110 mln to settle opioid charges in W. Va. - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Billionaire health-care investor Phillip Frost charged by SEC with pump-and-dump schemes - MarketWatch
Teva Pharmaceutical TEVA Pivots Trading Plans and Risk Controls - MarketWatch
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Teva Pharmaceutical Settles Opioid Suit With West Virginia - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
Teva Pharmaceuticals stock falls 11% after earnings miss - MarketWatch
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Teva Pharmaceuticals - Wikipedia
Latest twist in pharma love triangle as Teva pursues Mylan merger - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Opinion: Multinationals learn the limits of being big - MarketWatch
Teva stock drops on guidance, manufacturing problems - MarketWatch
Drug stocks move higher in late trading - MarketWatch
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
